ONCOMECA SAS is a French start-up designing a non-invasive eponym medical device (MD) which provides in vivo diagnosis of skin disorders including early stage 1 melanoma.
It is a class IIb medical device according to the EU regulation 2017/745. Our patented technology lies in the identification of early skin cancers using their mechanical markers combined to their visual characteristics. Our expertise has been miniaturized and automatized to provide an easy-to-use and 88% reliable technology!
It is intended for use by dermatologists and general practitioners and aims at revolutionizing skin cancer diagnosis to hasten patient care.
“At ONCOMECA, we innovate to provide early diagnosis for everybody.”
Julien Chlasta CEO, ONCOMECA
Co-founder & Chief Operating Officer